Lates News

According to a brief from AI Express, Pacific Securities released a research report on August 26, giving a buy rating to Hisun Group (000513.SZ). The rating reasons mainly include: 1) The formulation business maintains stable development; 2) The innovative drug pipeline drives future growth. (Daily Economic News)